Athersys Inc (ATHXQ)

[SH1TFORBRAINS]

To our knowledge, we are the only company that has an active program that is received Fast Track designation for the treatment of ARDS. We and our collaborators are confident that MultiStem can and will play an important role in treating patients with ARDS. And I would briefly like to summarize some of the clinical observations from our recently completed randomized double-blind placebo-controlled study that support that view.